Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction

被引：0
|
作者：
ChangDong Lin
Yue Li
YueBin Zhang
ZhaoYuan Liu
Xia Mu
Chenjian Gu
Jing Liu
Yutang Li
GuoHui Li
JianFeng Chen
机构：
[1] University of Chinese Academy of Sciences,State Key Laboratory of Cell Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
[2] Chinese Academy of Sciences,State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics
[3] Fudan University,Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College
[4] BSL-3 laboratory of Fudan University,School of Life Science, Hangzhou Institute for Advanced Study
[5] School of Basic Medical Sciences,undefined
[6] Shanghai Medical College,undefined
[7] Fudan University,undefined
[8] University of Chinese Academy of Sciences,undefined
来源：
Signal Transduction and Targeted Therapy | / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction (vol 6, 198, 2021)
    Lin, ChangDong
    Li, Yue
    Zhang, YueBin
    Liu, ZhaoYuan
    Mu, Xia
    Gu, Chenjian
    Liu, Jing
    Li, Yutang
    Li, GuoHui
    Chen, JianFeng
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [2] Identification and characterization of a monoclonal antibody blocking the SARS-CoV-2 spike protein–ACE2 interaction
    MengYa Yuan
    YaoYing Wan
    Cui Liu
    Yue Li
    ZhaoYuan Liu
    ChangDong Lin
    JianFeng Chen
    Cellular & Molecular Immunology, 2021, 18 : 1562 - 1564
  • [3] Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay
    Xiang, Yusen
    Zhai, Guanglei
    Li, Yaozong
    Wang, Mengge
    Chen, Xixiang
    Wang, Ruyu
    Xie, Hang
    Zhang, Weidong
    Ge, Guangbo
    Zhang, Qian
    Xu, Yechun
    Caflisch, Amedeo
    Xu, Jianrong
    Chen, Hongzhuan
    Chen, Lili
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 226 : 780 - 792
  • [4] Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations
    Tsai, Ming-Shao
    Shih, Wei-Tai
    Yang, Yao-Hsu
    Lin, Yu-Shih
    Chang, Geng-He
    Hsu, Cheng-Ming
    Yeh, Reming-Albert
    Shu, Li-Hsin
    Cheng, Yu-Ching
    Liu, Hung-Te
    Wu, Yu-Huei
    Wu, Yu-Heng
    Shen, Rou-Chen
    Wu, Ching-Yuan
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
  • [5] Ceftazidime exhibits a broad inhibition to the infection of SARS-CoV-2 prototype and Omicron variant in vitro by blocking spike protein-ACE2 interaction
    Zheng, Yun-zhe
    Liu, Zhao-yuan
    Li, Yue
    Lv, Xiao-ying
    Wu, Yi
    Huang, Meng-wen
    Pan, Xing-chao
    Chen, Jian-feng
    Lin, Chang-dong
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (9) : 1932 - 1934
  • [6] Ceftazidime exhibits a broad inhibition to the infection of SARS-CoV-2 prototype and Omicron variant in vitro by blocking spike protein-ACE2 interaction
    Yun-zhe Zheng
    Zhao-yuan Liu
    Yue Li
    Xiao-ying Lv
    Yi Wu
    Meng-wen Huang
    Xing-chao Pan
    Jian-feng Chen
    Chang-dong Lin
    Acta Pharmacologica Sinica, 2023, 44 : 1932 - 1934
  • [7] Potential inhibitors for blocking the interaction of the coronavirus SARS-CoV-2 spike protein and its host cell receptor ACE2
    Li, Changzhi
    Zhou, Hongjuan
    Guo, Lingling
    Xie, Dehuan
    He, Huiping
    Zhang, Hong
    Liu, Yixiu
    Peng, Lixia
    Zheng, Lisheng
    Lu, Wenhua
    Mei, Yan
    Liu, Zhijie
    Huang, Jie
    Wang, Mingdian
    Shu, Ditian
    Ding, Liuyan
    Lang, Yanhong
    Luo, Feifei
    Wang, Jing
    Huang, Bijun
    Huang, Peng
    Gao, Song
    Chen, Jindong
    Qian, Chao-Nan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [8] Potential inhibitors for blocking the interaction of the coronavirus SARS-CoV-2 spike protein and its host cell receptor ACE2
    Changzhi Li
    Hongjuan Zhou
    Lingling Guo
    Dehuan Xie
    Huiping He
    Hong Zhang
    Yixiu Liu
    Lixia Peng
    Lisheng Zheng
    Wenhua Lu
    Yan Mei
    Zhijie Liu
    Jie Huang
    Mingdian Wang
    Ditian Shu
    Liuyan Ding
    Yanhong Lang
    Feifei Luo
    Jing Wang
    Bijun Huang
    Peng Huang
    Song Gao
    Jindong Chen
    Chao-Nan Qian
    Journal of Translational Medicine, 20
  • [9] Direct blue 53, a biological dye, inhibits SARS-CoV-2 infection by blocking ACE2 and spike interaction in vitro and in vivo
    Xiao, Yu
    Wang, Ling
    Fang, Shi-song
    Luo, Fan
    Chen, Shu-liang
    Ye, Lin
    Hou, Wei
    VIROLOGY, 2023, 586 : 105 - 114
  • [10] Biphenyl furanocoumarin compounds inhibit SARS-CoV-2 spike pseudovirus infection by binding ACE2
    Lv, Yuexin
    Ge, Shuai
    Zhu, Qiumei
    Si, Min
    Wang, Cheng
    He, Huaizhen
    NEW JOURNAL OF CHEMISTRY, 2023, 47 (05) : 2651 - 2658
12345